Log In
Print
BCIQ
Print
Print this Print this
 

MGD010

  Manage Alerts
Collapse Summary General Information
Company MacroGenics Inc.
DescriptionBispecific antibody against Fc gamma receptor IIb (FCGR2B; CD32B) and CD79b molecule immunoglobulin-associated beta (CD79B; B29)
Molecular Target Fc gamma receptor IIb (FCGR2B) (CD32B) ; CD79b molecule immunoglobulin-associated beta (CD79B) (B29)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune disorders
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today